Drugs News and Research

RSS

Global health community calls for more effective, accessible TB treatment in MSF statement

"Patients, doctors and international aid groups are calling on donors and governments to support measures that would make treatment of drug-resistant tuberculosis more effective and accessible," Inter Press Service reports, noting, "The demands are being made amidst the recent or imminent approval of two new drugs" that some advocates say "present an historic opportunity to tackle the notoriously difficult-to-treat disease."

22 Mar 2013

Scientists find new way to move DNA through cells

Scientists have cracked a 35-year-old mystery about the workings of the natural motors that are serving as models for development of a futuristic genre of synthetic nanomotors that pump therapeutic DNA, RNA or drugs into individual diseased cells.

22 Mar 2013

Fralin Life Science Institute researchers use TALENS to alter mosquito genome

Virginia Tech researchers successfully used a gene disruption technique to change the eye color of a mosquito - a critical step toward new genetic strategies aimed at disrupting the transmission of diseases such as dengue fever.

22 Mar 2013

New hope for treating, preventing malaria

Scientists at Oregon Health & Science University and the Portland VA Medical Center have developed a drug that may represent one of the world's best hopes for treating and preventing malaria - a disease that kills more than one million people each year.

22 Mar 2013

Cocaine can be lethal for people living with HIV

Cocaine, already a damaging drug for those with healthy immune systems, can be lethal for those living with human immunodeficiency virus. Mudit Tyagi, Ph.D., assistant professor of medicine at the George Washington University School of Medicine and Health Sciences, has received two federally funded grants to study how dangerous this combination is in HIV patients.

22 Mar 2013

MU researchers redefine key regulatory process in defective protein responsible for cystic fibrosis

A little more than a year after the FDA approved Kalydeco (Vx-770), the first drug of its kind to treat the underlying cause of cystic fibrosis, University of Missouri researchers believe they have found exactly how this drug works and how to improve its effectiveness in the future.

22 Mar 2013

Findings provide structural basis for development of drugs to fight enterovirus 71 infection

New research findings may help scientists design drugs to treat a virus infection that causes potentially fatal brain swelling and paralysis in children.

22 Mar 2013

Fibromyalgia: an interview with Dr Frederick Wolfe, University of Kansas School of Medicine

Fibromyalgia is a common disorder that is diagnosed in people who have pain in many areas of their body together with important symptoms such as...

22 Mar 2013

Disinfectant mouthwashes may be effective against cancers of the mouth and throat

Patients who suffer from gingivitis are often advised to use disinfectant mouthwashes. In the future, the active ingredients in these products could be used in a completely different area: As scientists have reported in the journal Angewandte Chemie, Chlorhexidin and Alexidin increase programmed cell death and may be effective against cancers of the mouth and throat.

21 Mar 2013

HIV home tests: an interview with Dr Nitika Pant Pai, McGill University

30 years into the HIV epidemic, there is no vaccine in sight. Yet, even though there are fantastic and effective cheap and universally available drugs, and a treatment as prevention strategy is known to work, people do not wish to get tested for HIV! If everyone got tested, and treated, we could have brought the infection under control a long time ago!

21 Mar 2013

Report: Adults experiencing mental or substance use disorders more likely to smoke heavily than others

Adults aged 18 or older who experienced any mental illness or who have had a substance use disorder in the past year are more likely to smoke and to smoke more heavily than others, according to a new report by the Substance Abuse and Mental Health Services Administration.

21 Mar 2013

Alarming report on persistent side effects of antidepressant drugs published online

An alarming report from patient online websites on persistent side effects of antidepressant drugs has been published in one of the last issue of Psychotherapy and Psychosomatics by investigators from the University of Bologna and North America.

21 Mar 2013

Supreme Court considering generic drugmaker safety liability

The Supreme Court is weighing if generic drugmakers can be sued over the safety of their drugs or if federal regulators' safety approval is enough to block all such legal challenges.

21 Mar 2013

Turning three: Progress reports on health overhaul abound

As the law approaches its third birthday, news outlets examine a variety of issues surrounding its implementation.

21 Mar 2013

New class of anti-malarial compounds discovered

A group of researchers from 16 institutions around the world has identified a new class of anti-malarial compounds that target multiple stages of the malaria parasite's life cycle.

21 Mar 2013

New imaging agent detects, maps cancers that have reached lymph nodes

Researchers at the University of California, San Diego School of Medicine have shown that a new imaging dye, designed and developed at UC San Diego Moores Cancer Center, is an effective agent in detecting and mapping cancers that have reached the lymph nodes.

21 Mar 2013

Viewpoints: N.D. abortion law is 'repressive and extreme;' States identify 'promising' ideas to overhaul medical malpractice

Late last week, the North Dakota legislature passed a bill that would ban a woman from having an abortion as soon as the heartbeat of the fetus is detected, which can happen as early as six weeks into a pregnancy.

21 Mar 2013

Researchers develop promising drug candidate to treat psoriasis

Ben-Gurion University of the Negev researchers, in collaboration with Teva Pharmaceutical Industries Ltd., have developed a promising drug candidate to treat psoriasis.

21 Mar 2013

Advocates, public consider Medicare cost savings as debate continues

Medicare costs -- and controlling them -- are on the minds of the public, patient advocates, lawmakers and doctors as the debate spills off Capitol Hill and into American discourse.

21 Mar 2013

New biodegradable nanoparticles deliver inflammation-resolving drugs to sites of tissue injury

A multicenter team of researchers, including scientists at Columbia University Medical Center (CUMC), Brigham and Women's Hospital (BWH), Mount Sinai School of Medicine, and Massachusetts Institute of Technology, has developed biodegradable nanoparticles that are capable of delivering inflammation-resolving drugs to sites of tissue injury.

20 Mar 2013

Drugs News and Research

Global health community calls for more effective, accessible TB treatment in MSF statement

Scientists find new way to move DNA through cells

Fralin Life Science Institute researchers use TALENS to alter mosquito genome

New hope for treating, preventing malaria

Cocaine can be lethal for people living with HIV

MU researchers redefine key regulatory process in defective protein responsible for cystic fibrosis

Findings provide structural basis for development of drugs to fight enterovirus 71 infection

Fibromyalgia: an interview with Dr Frederick Wolfe, University of Kansas School of Medicine

Disinfectant mouthwashes may be effective against cancers of the mouth and throat

HIV home tests: an interview with Dr Nitika Pant Pai, McGill University

Report: Adults experiencing mental or substance use disorders more likely to smoke heavily than others

Alarming report on persistent side effects of antidepressant drugs published online

Supreme Court considering generic drugmaker safety liability

Turning three: Progress reports on health overhaul abound

New class of anti-malarial compounds discovered

New imaging agent detects, maps cancers that have reached lymph nodes

Viewpoints: N.D. abortion law is 'repressive and extreme;' States identify 'promising' ideas to overhaul medical malpractice

Researchers develop promising drug candidate to treat psoriasis

Advocates, public consider Medicare cost savings as debate continues

New biodegradable nanoparticles deliver inflammation-resolving drugs to sites of tissue injury

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News